• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 24715
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Reocclusion (1985); Vascular Dissection (3160); Restenosis (4576)
Date of Event 09/05/2018
Type of Reportable Event Serious Injury
Event or Problem Description
(b)(6) study.It was reported that restenosis occurred.In (b)(6) 2018, clinical status assessment identified the patient's qualifying condition as rutherford category 3.Subsequently, the index procedure was performed.The target lesion was located in the left superficial femoral artery (sfa) had 100% stenosis, reference vessel diameter of 5mm, a length of 100mm and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation using 4mm x 150mm balloon.Post pre-dilatation, standard percutaneous transluminal angioplasty (pta) was performed with 5mm x 150mm sterling balloon to the target lesion.Following, grade a dissection was noted; however, no action was taken.Post dilatation was also performed.The patient was discharged as an outpatient.In (b)(6) 2018, the patient developed restenosis in the left sfa.No action was taken to treat the event.
 
Event or Problem Description
Uxa25530 ranger ii sfa study it was reported that restenosis occurred.In (b)(6) 2018, clinical status assessment identified the patient's qualifying condition as rutherford category 3.Subsequently, the index procedure was performed.The target lesion was located in the left superficial femoral artery (sfa) had 100% stenosis, reference vessel diameter of 5mm, a length of 100mm and was classified as a tasc ii a lesion.The target lesion was treated with pre-dilatation using 4mm x 150mm balloon.Post pre-dilatation, standard percutaneous transluminal angioplasty (pta) was performed with 5mm x 150mm sterling balloon to the target lesion.Following, grade a dissection was noted however, no action was taken.Post dilatation was also performed.The patient was discharged as an outpatient.In (b)(6) 2018, the patient developed restenosis in the left sfa.No action was taken to treat the event.It was further reported that in (b)(6) 2022, the event was considered as recovered/resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERLING
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key8232669
Report Number2134265-2018-64891
Device Sequence Number195337
Product Code LIT
UDI-Device Identifier08714729845362
UDI-Public08714729845362
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K132430
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/05/2019
Device Model Number24715
Device Catalogue Number24715
Device Lot Number0021840677
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/14/2018
Supplement Date Received by Manufacturer07/04/2023
Initial Report FDA Received Date01/09/2019
Supplement Report FDA Received Date07/31/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/09/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age82 YR
Patient SexFemale
Patient RaceWhite
-
-